1080 related articles for article (PubMed ID: 22049615)
1. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615
[TBL] [Abstract][Full Text] [Related]
2. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
3. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Bowen DT; Pippard MJ
Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409
[TBL] [Abstract][Full Text] [Related]
4. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization.
Flores-Figueroa E; Arana-Trejo RM; Gutiérrez-Espíndola G; Pérez-Cabrera A; Mayani H
Leuk Res; 2005 Feb; 29(2):215-24. PubMed ID: 15607371
[TBL] [Abstract][Full Text] [Related]
6. Characterization of bone marrow stromal abnormalities in a patient with constitutional trisomy 8 mosaicism and myelodysplastic syndrome.
Narendran A; Hawkins LM; Ganjavi H; Vanek W; Gee MF; Barlow JW; Johnson G; Malkin D; Freedman MH
Pediatr Hematol Oncol; 2004; 21(3):209-21. PubMed ID: 15202160
[TBL] [Abstract][Full Text] [Related]
7. Sca-1 / c-Kit receptor expression and apoptosis pattern in ENU induced MDS mice.
Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
J Stem Cells; 2009; 4(4):229-41. PubMed ID: 20720596
[TBL] [Abstract][Full Text] [Related]
8. Pesticide induced marrow toxicity and effects on marrow cell population and on hematopoietic stroma.
Chatterjee S; Basak P; Chaklader M; Das P; Pereira JA; Chaudhuri S; Law S
Exp Toxicol Pathol; 2013 Mar; 65(3):287-95. PubMed ID: 22005501
[TBL] [Abstract][Full Text] [Related]
9. Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Peddie CM; Bowen DT; Pippard MJ
Leukemia; 2002 May; 16(5):785-90. PubMed ID: 11986938
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow niche in the myelodysplastic syndromes.
Cogle CR; Saki N; Khodadi E; Li J; Shahjahani M; Azizidoost S
Leuk Res; 2015 Oct; 39(10):1020-7. PubMed ID: 26276090
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow stromal culture from patients with myelodysplastic syndromes and patients at different stages of acute nonlymphocytic leukaemia.
Elstner E; Wächter M; Ihle R
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(1):167-74. PubMed ID: 2472321
[TBL] [Abstract][Full Text] [Related]
12. Blast colony forming cell-binding capacity of bone marrow stroma from myelodysplastic patients.
Gidáli J; Fehér I; Hollán SR
Stem Cells; 1996 Sep; 14(5):577-83. PubMed ID: 8888498
[TBL] [Abstract][Full Text] [Related]
13. Programmed cell death is an intrinsic feature of MDS progenitors, predominantly found in the cluster-forming cells.
Span LF; Vierwinden G; Pennings AH; Boezeman JB; Raymakers RA; de Witte T
Exp Hematol; 2005 Apr; 33(4):435-42. PubMed ID: 15781334
[TBL] [Abstract][Full Text] [Related]
14. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.
Varga G; Kiss J; Várkonyi J; Vas V; Farkas P; Pálóczi K; Uher F
Pathol Oncol Res; 2007; 13(4):311-9. PubMed ID: 18158566
[TBL] [Abstract][Full Text] [Related]
15. Functional characteristics of mesenchymal stem cells derived from bone marrow of patients with myelodysplastic syndromes.
Zhao ZG; Xu W; Yu HP; Fang BL; Wu SH; Li F; Li WM; Li QB; Chen ZC; Zou P
Cancer Lett; 2012 Apr; 317(2):136-43. PubMed ID: 22240014
[TBL] [Abstract][Full Text] [Related]
16. Abnormalities of adherent layers grown from bone marrow of patients with myelodysplasia.
Tennant GB; Walsh V; Truran LN; Edwards P; Mills KI; Burnett AK
Br J Haematol; 2000 Dec; 111(3):853-62. PubMed ID: 11122147
[TBL] [Abstract][Full Text] [Related]
17. MDS-like experimental myelodysplasia: multilineage abnormal hematopoiesis in transgenic mice harboring the SV40 large T antigen under an immunoglobulin enhancer.
Furuta Y; Aizawa S; Suda Y; Ikawa Y; Nishikawa S; Hayashi S; Hirabayashi Y; Inoue T
Exp Hematol; 1993 Jun; 21(6):806-15. PubMed ID: 8500578
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathology of myelodysplastic syndromes: biology of medullary stromal and hematopoietic cells (review).
Kitagawa M; Kurata M; Yamamoto K; Abe S; Suzuki S; Umeda S
Mol Med Rep; 2011; 4(4):591-6. PubMed ID: 21584497
[TBL] [Abstract][Full Text] [Related]
19. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
20. COX-2 expression in fibroblast aggregates as a functional indicator for the anti-inflammatory activity of leukemia patients' bone marrow-derived hematopoietic cells.
Egyudova K; Fajtova M; Cizmar A; Korhonen M; Gyarfas J; Kankuri E; Bizik J
Neoplasma; 2012; 59(5):574-83. PubMed ID: 22668024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
